Huntington’s Disease Biomarker Study

Longitudinal Biospecimen Collection for Mitochondrial Metabolomics in Huntington’s Disease

Affected Nerve cells, concept for Neurological Diseases,tumors,brain surgery.
AGE: 20-85 years old
TYPE: Observational and Sample Collection Study
CONDITION: Huntington’s Disease

Learn More About This Research Study

This is a research study being conducted at University Hospitals. For more information, please contact Ashley Hawkins, the study coordinator at 216-844-1800 or complete the online form below.

Study Purpose

The purpose of this study is to identify small molecules that can be measured in the blood and spinal fluid to determine the stage and severity of Huntington’s Disease and whether or not a person has the disease.

Who Can Participate

Participants between the 20 and 80 years of age diagnosed with Huntington’s Disease and do not have any other progressive neurological conditions may be eligible for this study. Participants without any neurological disease may also be eligible to participate.

Request More Information

To learn more about this study, please fill out the form below to request more information.


Study ID

  • STUDY20181082